1 Introduction Shared decision-making between the physician and the patient is a class 1 recommendation by the clinical practice guidelines for coronary artery revascularization, particularly in patients with significant left main (LM) coronary artery disease of low and intermediate anatomical complexity [ 1 ]. Conveying clinical trial results to patients in the form of Hazard Ratios (HR) can be challenging due to the relative nature of this metric. Additionally, hazard ratios from cox regression models assume proportional effect size throughout the follow-up period which is not usually the case in surgical vs percutaneous intervention studies. Restricted mean survival time (RMST) is an alternative or a supplement to the hazard ratios for reporting the effect of an intervention in randomized clinical trials. RMST quantifies the delay of an outcome during a specified (restricted) interval and corresponds to the difference between the areas under the 2 survival curves for the intervention and control groups. The results of an RMST analysis are easily interpreted even by lay persons and are free of the assumptions from a proportional hazard model [ 2 ]. Here, we sought to investigate the impact of PCI vs CABG on clinical outcomes in LM disease using RMST methodology.